2009 Press Releases
| Date | Title | |
| December 17, 2009 | SPECTRAL DIAGNOSTICS RAISES $14 MILLION AND ENTERS INTO STRATEGIC COLLABORATION WITH BIOMS MEDICAL TO COMMERCIALIZE TREATMENT FOR SEPSIS | |
| December 17, 2009 | BIOMS MEDICAL PROVIDES CORPORATE UPDATE | |
| November 12, 2009 | BioMS Medical Announces Third Quarter 2009 Results | |
| September 2, 2009 | BioMS Medical Provides Update on Dirucotide | |
| July 27, 2009 | Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial | |
| July 17, 2009 | BioMS Medical Announces Second Quarter 2009 Results | |
| May 28, 2009 | BioMS Medical to Present at the 2009 Symposium for the Canadian Society For Pharmaceutical Sciences | |
| May 14, 2009 | BioMS Medical to Participate in Panel Session at BIO International Convention 2009 | |
| May 11, 2009 | BioMS Medical Announces First Quarter 2009 Results | |
| April 29, 2009 | BioMS Medical to Present at Alberta Economic Forum in Geneva | |
| April 24, 2009 | BioMS Medical to Present at BioFinance 2009 | |
| April 21, 2009 | BioMS Medical’s Pivotal International Multiple Sclerosis Trial Receives Positive Review From Data Safety Monitoring Board | |
| April 14, 2009 | BioMS Medical’s Phase III U.S. Multiple Sclerosis Trial Receives Positive Safety Review From Data Safety Monitoring Board | |
| March 17, 2009 | BioMS Medical Announces 2008 Year End Results | |
| March 2, 2009 | BioMS Medical Warrant Extension | |
| February 6, 2009 | BioMS Medical to Participate in Bioindustry Session at BioPartnering North America | |
| February 5, 2009 | BioMS Medical to Present at BIO CEO and Investor Conference | |
| January 30, 2009 | BioMS Medical Reports Results of Exploratory Phase II Trial of Dirucotide in Relapsing-Remitting MS |
Subscribe via RSS Feed